| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | allyl-alcohol dehydrogenase activity | 8.80e-08 | 4 | 57 | 3 | GO:0047655 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 7.85e-06 | 14 | 57 | 3 | GO:0001758 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 7.85e-06 | 14 | 57 | 3 | GO:0004032 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NADP+) activity | 9.79e-06 | 15 | 57 | 3 | GO:0052650 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 4.79e-05 | 4 | 57 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 6.14e-05 | 27 | 57 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 1.03e-04 | 32 | 57 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 1.19e-04 | 6 | 57 | 2 | GO:0045550 | |
| GeneOntologyMolecularFunction | NADP+ binding | 2.85e-04 | 9 | 57 | 2 | GO:0070401 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 3.48e-04 | 48 | 57 | 3 | GO:0016620 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4.75e-04 | 127 | 57 | 4 | GO:0016616 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 5.49e-04 | 56 | 57 | 3 | GO:0016903 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 6.12e-04 | 13 | 57 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 6.49e-04 | 138 | 57 | 4 | GO:0016614 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase adaptor activity | 1.19e-03 | 18 | 57 | 2 | GO:0005068 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 1.33e-03 | 19 | 57 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 1.47e-03 | 20 | 57 | 2 | GO:0004303 | |
| GeneOntologyMolecularFunction | protein kinase activity | 1.53e-03 | 600 | 57 | 7 | GO:0004672 | |
| GeneOntologyMolecularFunction | retinal binding | 1.62e-03 | 21 | 57 | 2 | GO:0016918 | |
| GeneOntologyMolecularFunction | myosin binding | 1.85e-03 | 85 | 57 | 3 | GO:0017022 | |
| GeneOntologyMolecularFunction | NADPH binding | 2.49e-03 | 26 | 57 | 2 | GO:0070402 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 3.73e-03 | 363 | 57 | 5 | GO:0106310 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 3.91e-03 | 709 | 57 | 7 | GO:0016773 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.99e-03 | 33 | 57 | 2 | GO:0033764 | |
| GeneOntologyMolecularFunction | acetylgalactosaminyltransferase activity | 4.48e-03 | 35 | 57 | 2 | GO:0008376 | |
| GeneOntologyMolecularFunction | aromatase activity | 4.48e-03 | 35 | 57 | 2 | GO:0070330 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 5.54e-03 | 39 | 57 | 2 | GO:0016229 | |
| GeneOntologyMolecularFunction | kinase activity | 5.85e-03 | 764 | 57 | 7 | GO:0016301 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 5.94e-03 | 766 | 57 | 7 | GO:0016491 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 5.98e-03 | 129 | 57 | 3 | GO:0035591 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 6.71e-03 | 43 | 57 | 2 | GO:0001965 | |
| GeneOntologyMolecularFunction | retinoid binding | 8.30e-03 | 48 | 57 | 2 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 8.64e-03 | 49 | 57 | 2 | GO:0019840 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 8.64e-03 | 49 | 57 | 2 | GO:0016712 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 8.78e-03 | 446 | 57 | 5 | GO:0004674 | |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 1.04e-02 | 54 | 57 | 2 | GO:0030159 | |
| GeneOntologyMolecularFunction | vitamin binding | 1.10e-02 | 161 | 57 | 3 | GO:0019842 | |
| GeneOntologyMolecularFunction | iron ion binding | 1.19e-02 | 166 | 57 | 3 | GO:0005506 | |
| GeneOntologyBiologicalProcess | retinol metabolic process | 1.39e-05 | 53 | 57 | 4 | GO:0042572 | |
| GeneOntologyBiologicalProcess | cellular response to aldehyde | 2.21e-05 | 20 | 57 | 3 | GO:0110096 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 1.07e-04 | 89 | 57 | 4 | GO:0001523 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 1.33e-04 | 94 | 57 | 4 | GO:0016101 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 1.39e-04 | 180 | 57 | 5 | GO:0120254 | |
| GeneOntologyBiologicalProcess | cellular response to progesterone stimulus | 1.56e-04 | 7 | 57 | 2 | GO:0071393 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 2.04e-04 | 105 | 57 | 4 | GO:0006721 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 2.11e-04 | 106 | 57 | 4 | GO:0034308 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 2.67e-04 | 9 | 57 | 2 | GO:0044597 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 3.33e-04 | 10 | 57 | 2 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 3.33e-04 | 10 | 57 | 2 | GO:0030647 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 3.33e-04 | 10 | 57 | 2 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 3.96e-04 | 125 | 57 | 4 | GO:0046425 | |
| GeneOntologyBiologicalProcess | retina vasculature morphogenesis in camera-type eye | 4.06e-04 | 11 | 57 | 2 | GO:0061299 | |
| Domain | ALDOKETO_REDUCTASE_1 | 3.19e-06 | 10 | 57 | 3 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 3.19e-06 | 10 | 57 | 3 | IPR018170 | |
| Domain | Aldo/keto_reductase | 3.19e-06 | 10 | 57 | 3 | IPR020471 | |
| Domain | ALDOKETO_REDUCTASE_2 | 3.19e-06 | 10 | 57 | 3 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 3.19e-06 | 10 | 57 | 3 | PS00063 | |
| Domain | - | 1.47e-05 | 16 | 57 | 3 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 1.78e-05 | 17 | 57 | 3 | IPR023210 | |
| Domain | Aldo_ket_red | 1.78e-05 | 17 | 57 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 1.78e-05 | 17 | 57 | 3 | IPR001395 | |
| Domain | FN3_dom | 4.37e-04 | 209 | 57 | 5 | IPR003961 | |
| Domain | PROTEIN_KINASE_DOM | 7.23e-04 | 493 | 57 | 7 | PS50011 | |
| Domain | - | 1.50e-03 | 74 | 57 | 3 | 3.40.50.410 | |
| Domain | fn3 | 1.51e-03 | 162 | 57 | 4 | PF00041 | |
| Domain | VWFA | 2.01e-03 | 82 | 57 | 3 | PS50234 | |
| Domain | VWA | 2.16e-03 | 84 | 57 | 3 | SM00327 | |
| Domain | FN3 | 2.44e-03 | 185 | 57 | 4 | SM00060 | |
| Domain | PROTEIN_KINASE_ATP | 2.68e-03 | 459 | 57 | 6 | PS00107 | |
| Domain | FN3 | 3.18e-03 | 199 | 57 | 4 | PS50853 | |
| Domain | PROTEIN_KINASE_TYR | 3.24e-03 | 97 | 57 | 3 | PS00109 | |
| Domain | RICIN | 3.29e-03 | 28 | 57 | 2 | SM00458 | |
| Domain | RICIN_B_LECTIN | 3.29e-03 | 28 | 57 | 2 | PS50231 | |
| Domain | VWF_A | 3.44e-03 | 99 | 57 | 3 | IPR002035 | |
| Domain | Prot_kinase_dom | 3.66e-03 | 489 | 57 | 6 | IPR000719 | |
| Domain | Ricin_B_lectin | 3.77e-03 | 30 | 57 | 2 | IPR000772 | |
| Domain | Protein_kinase_ATP_BS | 5.91e-03 | 379 | 57 | 5 | IPR017441 | |
| Domain | Kinase-like_dom | 6.02e-03 | 542 | 57 | 6 | IPR011009 | |
| Pathway | REACTOME_ESTROGEN_BIOSYNTHESIS | 1.47e-04 | 7 | 38 | 2 | MM14740 | |
| Pathway | REACTOME_METABOLISM_OF_STEROID_HORMONES | 1.79e-04 | 41 | 38 | 3 | MM14757 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 2.52e-04 | 9 | 38 | 2 | M27143 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 3.04e-04 | 121 | 38 | 4 | M39823 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 3.83e-04 | 11 | 38 | 2 | MM14863 | |
| Pubmed | Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes. | 4.88e-09 | 3 | 60 | 3 | 17381426 | |
| Pubmed | 4.87e-08 | 5 | 60 | 3 | 10092857 | ||
| Pubmed | Impaired Barrier Function and Immunity in the Colon of Aldo-Keto Reductase 1B8 Deficient Mice. | 2.93e-06 | 2 | 60 | 2 | 33644071 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 12732097 | ||
| Pubmed | Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse. | 2.93e-06 | 2 | 60 | 2 | 34954342 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 15745835 | ||
| Pubmed | Aldo Keto Reductases AKR1B1 and AKR1B10 in Cancer: Molecular Mechanisms and Signaling Networks. | 2.93e-06 | 2 | 60 | 2 | 33945128 | |
| Pubmed | Evaluation of compound selectivity of aldo-keto reductases using differential scanning fluorimetry. | 2.93e-06 | 2 | 60 | 2 | 28003428 | |
| Pubmed | Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway. | 2.93e-06 | 2 | 60 | 2 | 25120755 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 21087085 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 8526877 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 24100137 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 23146748 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 36518763 | ||
| Pubmed | Identification and characterization of a novel human aldose reductase-like gene. | 2.93e-06 | 2 | 60 | 2 | 9565553 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 25538260 | ||
| Pubmed | Functional expression of novel human and murine AKR1B genes. | 2.93e-06 | 2 | 60 | 2 | 21276782 | |
| Pubmed | Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer. | 2.93e-06 | 2 | 60 | 2 | 28929377 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 31911858 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 21329684 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 7578036 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 8541228 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 32628753 | ||
| Pubmed | Aldo-keto reductases-mediated cytotoxicity of 2-deoxyglucose: A novel anticancer mechanism. | 2.93e-06 | 2 | 60 | 2 | 29617059 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 7510692 | ||
| Pubmed | Structural and functional analysis of the apoptosis-associated tyrosine kinase (AATYK) family. | 8.77e-06 | 3 | 60 | 2 | 17651901 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 21179467 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | IGF1R SH2B3 SPEG SIPA1L3 LMTK2 HECTD1 GCN1 ITGB4 ANKRD33B CREB3 | 1.79e-05 | 1105 | 60 | 10 | 35748872 |
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 26291391 | ||
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 28873464 | ||
| Pubmed | 5.34e-05 | 42 | 60 | 3 | 23444366 | ||
| Pubmed | 8.14e-05 | 8 | 60 | 2 | 20837989 | ||
| Pubmed | Germ cell differentiation and synaptonemal complex formation are disrupted in CPEB knockout mice. | 1.05e-04 | 9 | 60 | 2 | 11702780 | |
| Pubmed | GWAS of longevity in CHARGE consortium confirms APOE and FOXO3 candidacy. | 1.31e-04 | 10 | 60 | 2 | 25199915 | |
| Pubmed | Sox2-Evf2 lncRNA-mediated mechanisms of chromosome topological control in developing forebrain. | 2.26e-04 | 13 | 60 | 2 | 33593819 | |
| Pubmed | Stress granules and mTOR are regulated by membrane atg8ylation during lysosomal damage. | 2.63e-04 | 14 | 60 | 2 | 36179369 | |
| Pubmed | 4.40e-04 | 18 | 60 | 2 | 23534349 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 6.87e-04 | 861 | 60 | 7 | 36931259 | |
| Pubmed | 9.99e-04 | 27 | 60 | 2 | 19208226 | ||
| Pubmed | 1.02e-03 | 114 | 60 | 3 | 28245920 | ||
| Pubmed | 1.15e-03 | 29 | 60 | 2 | 19094228 | ||
| Pubmed | 1.25e-03 | 122 | 60 | 3 | 30773093 | ||
| Pubmed | Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase. | 1.43e-03 | 128 | 60 | 3 | 25332235 | |
| Interaction | AKR1B15 interactions | 8.05e-06 | 14 | 58 | 3 | int:AKR1B15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q33 | 6.22e-05 | 58 | 60 | 3 | chr7q33 | |
| Cytoband | 5p15.2 | 5.77e-04 | 27 | 60 | 2 | 5p15.2 | |
| Cytoband | 7q33 | 1.33e-03 | 41 | 60 | 2 | 7q33 | |
| GeneFamily | Aldo-keto reductases | 3.83e-06 | 15 | 38 | 3 | 399 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 8.02e-05 | 40 | 38 | 3 | 321 | |
| GeneFamily | Fibronectin type III domain containing | 4.57e-03 | 160 | 38 | 3 | 555 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.20e-06 | 186 | 60 | 5 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 7.39e-06 | 200 | 60 | 5 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 7.39e-06 | 200 | 60 | 5 | 3813fa1ee1462ba83fd8b6253070f46f0b063084 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 7.39e-06 | 200 | 60 | 5 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.39e-06 | 200 | 60 | 5 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| Drug | Glyceraldehyde | 1.86e-06 | 10 | 58 | 3 | ctd:D005985 | |
| Drug | Pentanones | 6.38e-06 | 2 | 58 | 2 | ctd:D010422 | |
| Drug | 4-hydroxyretinal | 6.38e-06 | 2 | 58 | 2 | ctd:C057180 | |
| Drug | 4-oxoretinaldehyde | 6.38e-06 | 2 | 58 | 2 | ctd:C099660 | |
| Drug | propioin | 6.38e-06 | 2 | 58 | 2 | ctd:C523189 | |
| Drug | dehydroretinal | 6.38e-06 | 2 | 58 | 2 | ctd:C017184 | |
| Drug | alrestatin | 6.98e-06 | 15 | 58 | 3 | CID000002120 | |
| Drug | Pyrithyldione [77-04-3]; Down 200; 24uM; MCF7; HT_HG-U133A | 1.05e-05 | 196 | 58 | 6 | 3482_DN | |
| Drug | D-arabinitol | 1.07e-05 | 114 | 58 | 5 | CID000000827 | |
| Drug | benzo(a)pyrene-7,8-dione | 1.73e-05 | 20 | 58 | 3 | ctd:C076588 | |
| Drug | benzo(a)pyrene-7,8-dione | 1.73e-05 | 20 | 58 | 3 | CID000105020 | |
| Drug | 2,4-hexadienal | 1.91e-05 | 3 | 58 | 2 | ctd:C079389 | |
| Drug | Acetoin | 1.91e-05 | 3 | 58 | 2 | ctd:D000093 | |
| Drug | 2,3-butylene glycol | 1.91e-05 | 3 | 58 | 2 | ctd:C026978 | |
| Drug | 5-Isothiocyanatoalrestatin | 3.81e-05 | 4 | 58 | 2 | CID000124861 | |
| Drug | 5-azidoalrestatin | 3.81e-05 | 4 | 58 | 2 | CID000128442 | |
| Drug | 5-(3-Thienyl)tetrazol-1-yl)acetic acid | 3.81e-05 | 4 | 58 | 2 | CID003035658 | |
| Drug | FR-62765 | 3.81e-05 | 4 | 58 | 2 | CID000128354 | |
| Drug | M7HEQ | 3.81e-05 | 4 | 58 | 2 | CID006452329 | |
| Drug | 2,5-DHBQOP | 3.81e-05 | 4 | 58 | 2 | CID000069213 | |
| Drug | NAP-HEX-Q | 3.81e-05 | 4 | 58 | 2 | CID005487149 | |
| Drug | WF-2421 | 3.81e-05 | 4 | 58 | 2 | CID000195567 | |
| Drug | danshenol B | 3.81e-05 | 4 | 58 | 2 | CID003083515 | |
| Drug | 4-chloro-3-hydroxybutanoate | 3.81e-05 | 4 | 58 | 2 | CID010129995 | |
| Drug | iodomethanesulfonamide | 3.81e-05 | 4 | 58 | 2 | CID000519939 | |
| Drug | salviaflaside | 3.81e-05 | 4 | 58 | 2 | CID006438919 | |
| Drug | matteuorienate A | 3.81e-05 | 4 | 58 | 2 | CID000190958 | |
| Drug | zopolrestat | 4.39e-05 | 27 | 58 | 3 | CID000001613 | |
| Drug | M79175 | 6.35e-05 | 5 | 58 | 2 | CID000115090 | |
| Drug | xanthone-2 | 6.35e-05 | 5 | 58 | 2 | CID005384285 | |
| Drug | AC1NE042 | 6.35e-05 | 5 | 58 | 2 | CID004634410 | |
| Drug | AC1L4VGL | 6.35e-05 | 5 | 58 | 2 | CID000213726 | |
| Drug | 4-chloro-3-nitrobenzaldehyde | 6.35e-05 | 5 | 58 | 2 | CID000085505 | |
| Drug | 2,3-hexanedione | 6.35e-05 | 5 | 58 | 2 | ctd:C043231 | |
| Drug | ICI 105552 | 6.35e-05 | 5 | 58 | 2 | CID000133677 | |
| Drug | 2-(2,3,6-Trihydroxy-4-carboxyphenyl)ellagic acid | 6.35e-05 | 5 | 58 | 2 | CID006918808 | |
| Drug | ICI 222155 | 6.35e-05 | 5 | 58 | 2 | CID000195716 | |
| Drug | DN-108 | 6.35e-05 | 5 | 58 | 2 | CID000183791 | |
| Drug | AD-5467 | 6.35e-05 | 5 | 58 | 2 | CID000197383 | |
| Drug | BAL-ARI8 | 6.35e-05 | 5 | 58 | 2 | CID000130098 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 6.70e-05 | 31 | 58 | 3 | ctd:C017228 | |
| Drug | phenanthrene trans-1,2-dihydrodiol | 9.50e-05 | 6 | 58 | 2 | CID000115062 | |
| Drug | ICI 215918 | 9.50e-05 | 6 | 58 | 2 | CID000129688 | |
| Drug | AC1L28UN | 9.50e-05 | 6 | 58 | 2 | CID000068017 | |
| Drug | M16287 | 9.50e-05 | 6 | 58 | 2 | CID000188399 | |
| Drug | p225 | 9.50e-05 | 6 | 58 | 2 | CID000014589 | |
| Drug | ADN-138 | 9.50e-05 | 6 | 58 | 2 | CID000127323 | |
| Drug | BAPSG | 9.50e-05 | 6 | 58 | 2 | CID000130998 | |
| Drug | 1,2,4-triazol-3-one | 9.50e-05 | 6 | 58 | 2 | CID011073339 | |
| Drug | capillarisin | 9.50e-05 | 6 | 58 | 2 | CID005281342 | |
| Drug | 3,5-dichlorosalicylic acid | 9.50e-05 | 6 | 58 | 2 | CID000009445 | |
| Drug | celastrol; Down 200; 2.5uM; MCF7; HT_HG-U133A_EA | 1.14e-04 | 187 | 58 | 5 | 887_DN | |
| Drug | 4-nitrobenzaldehyde | 1.33e-04 | 7 | 58 | 2 | ctd:C029915 | |
| Drug | myrciacitrin I | 1.33e-04 | 7 | 58 | 2 | CID000183137 | |
| Drug | friedelane | 1.33e-04 | 7 | 58 | 2 | CID000634354 | |
| Drug | 3-formylbenzoic acid | 1.33e-04 | 7 | 58 | 2 | CID000012077 | |
| Drug | tetramethylene glutaric acid | 1.33e-04 | 7 | 58 | 2 | CID000085558 | |
| Drug | guaijaverin | 1.33e-04 | 7 | 58 | 2 | CID005317847 | |
| Drug | desmanthin-1 | 1.33e-04 | 7 | 58 | 2 | CID005316590 | |
| Drug | 5213008; Up 200; 18uM; MCF7; HT_HG-U133A_EA | 1.36e-04 | 194 | 58 | 5 | 898_UP | |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HG-U133A | 1.39e-04 | 195 | 58 | 5 | 489_DN | |
| Drug | Roxithromycin [80214-83-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 3331_UP | |
| Drug | Ethoxyquin | 1.45e-04 | 40 | 58 | 3 | ctd:D005015 | |
| Drug | Diloxanide furoate [3736-81-0]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 6679_UP | |
| Drug | Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 2308_UP | |
| Drug | genistein; Down 200; 10uM; PC3; HT_HG-U133A | 1.49e-04 | 198 | 58 | 5 | 1235_DN | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 1.49e-04 | 198 | 58 | 5 | 4412_UP | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.49e-04 | 198 | 58 | 5 | 4074_DN | |
| Drug | Rimexolone [49697-38-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.53e-04 | 199 | 58 | 5 | 5517_DN | |
| Drug | Promethazine hydrochloride [58-33-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.56e-04 | 200 | 58 | 5 | 6477_UP | |
| Drug | erythritol 4-phosphate | 1.77e-04 | 8 | 58 | 2 | CID000192838 | |
| Drug | 4-hydroxynonanoate | 1.77e-04 | 8 | 58 | 2 | CID000134653 | |
| Drug | Risarestat | 1.77e-04 | 8 | 58 | 2 | CID000133264 | |
| Drug | 6-pyridoxyllysine | 1.77e-04 | 8 | 58 | 2 | CID000160700 | |
| Drug | propranolol glycol | 1.77e-04 | 8 | 58 | 2 | CID000037369 | |
| Drug | 1,2-diaminoguanidine | 1.77e-04 | 8 | 58 | 2 | CID000170039 | |
| Drug | 20-CHO-LTB4 | 1.77e-04 | 8 | 58 | 2 | CID006449839 | |
| Drug | CP-166,572 | 1.77e-04 | 8 | 58 | 2 | CID000132302 | |
| Drug | alcophosphamide | 1.77e-04 | 8 | 58 | 2 | CID000098612 | |
| Drug | eutypine | 1.77e-04 | 8 | 58 | 2 | CID000129326 | |
| Drug | SG-210 | 1.77e-04 | 8 | 58 | 2 | CID000132542 | |
| Drug | NSC633676 | 1.77e-04 | 8 | 58 | 2 | CID000133894 | |
| Drug | 3 Na | 1.77e-04 | 8 | 58 | 2 | CID000157838 | |
| Drug | naphthalene-1,2-dihydrodiol | 2.06e-04 | 45 | 58 | 3 | CID000000362 | |
| Drug | Solvent Yellow-?14 | 2.20e-04 | 46 | 58 | 3 | CID005354458 | |
| Drug | AL3152 | 2.27e-04 | 9 | 58 | 2 | CID000159501 | |
| Drug | AC1Q5HJP | 2.27e-04 | 9 | 58 | 2 | CID000000067 | |
| Drug | 3-deoxyfructose | 2.27e-04 | 9 | 58 | 2 | CID003080627 | |
| Drug | potassium amyl xanthate | 2.27e-04 | 9 | 58 | 2 | CID000017635 | |
| Drug | metyrapol | 2.27e-04 | 9 | 58 | 2 | CID000161210 | |
| Drug | mycaminose | 2.83e-04 | 10 | 58 | 2 | CID000160504 | |
| Drug | 5-OH-VPA | 2.83e-04 | 10 | 58 | 2 | CID000135243 | |
| Drug | azapetine | 2.83e-04 | 10 | 58 | 2 | CID000008966 | |
| Drug | 2,3-hexanedione | 2.83e-04 | 10 | 58 | 2 | CID000019707 | |
| Drug | Hexanones | 2.83e-04 | 10 | 58 | 2 | ctd:D006588 | |
| Drug | 4-OH-VPA | 2.83e-04 | 10 | 58 | 2 | CID000134466 | |
| Drug | 3-fluoro-3-deoxy-D-glucose | 2.83e-04 | 10 | 58 | 2 | CID000122305 | |
| Drug | lys-val | 2.83e-04 | 10 | 58 | 2 | CID000140709 | |
| Drug | DB289 | 2.83e-04 | 10 | 58 | 2 | CID005480200 | |
| Drug | Dihydroxydihydrobenzopyrenes | 3.46e-04 | 11 | 58 | 2 | ctd:D004101 | |
| Disease | aldose reductase measurement | 2.35e-05 | 4 | 59 | 2 | EFO_0801364 | |
| Disease | symmetrical dimethylarginine measurement | 1.40e-04 | 9 | 59 | 2 | EFO_0006523 | |
| Disease | white matter growth measurement | 1.40e-04 | 9 | 59 | 2 | EFO_0009335 | |
| Disease | Endometrial Neoplasms | 2.17e-04 | 58 | 59 | 3 | C0014170 | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 3.52e-04 | 14 | 59 | 2 | DOID:9743 (implicated_via_orthology) | |
| Disease | Endometrial Carcinoma | 4.11e-04 | 72 | 59 | 3 | C0476089 | |
| Disease | X-24309 measurement | 7.30e-04 | 20 | 59 | 2 | EFO_0800872 | |
| Disease | testosterone measurement | HMCN1 DLGAP4 NUFIP2 AKR1B15 DAP AKR1B1 USH2A ARHGEF15 IFNAR2 | 9.15e-04 | 1275 | 59 | 9 | EFO_0004908 |
| Disease | uric acid measurement | 1.36e-03 | 610 | 59 | 6 | EFO_0004761 | |
| Disease | mean corpuscular hemoglobin concentration | 1.54e-03 | 1105 | 59 | 8 | EFO_0004528 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 1.76e-03 | 31 | 59 | 2 | C1335167 | |
| Disease | hyperuricemia | 1.99e-03 | 33 | 59 | 2 | EFO_0009104 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 2.63e-03 | 137 | 59 | 3 | EFO_0007795, EFO_0010724 | |
| Disease | cataract (implicated_via_orthology) | 2.64e-03 | 38 | 59 | 2 | DOID:83 (implicated_via_orthology) | |
| Disease | rosacea severity measurement | 3.21e-03 | 147 | 59 | 3 | EFO_0009180 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 3.68e-03 | 45 | 59 | 2 | DOID:8947 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PEPAPWQALPVLSEK | 21 | Q96EY9 | |
| DKDDQEWESPSPPKP | 41 | P51397 | |
| LPPRLLEKSDNPYPW | 886 | Q96NH3 | |
| DPEASKASPLPFEPW | 421 | Q9C073 | |
| GPPLPAENKWRFTPE | 291 | Q9BYV8 | |
| NPKVWPNPEVFDPFR | 421 | Q02928 | |
| PDRPWAKPEDPSLLE | 216 | O60218 | |
| SSAPNKPLDWLDPMP | 101 | Q8N268 | |
| IFWEPPAASLKPPAL | 61 | O94989 | |
| EFNMWLPPPEALPAD | 346 | Q9Y4B4 | |
| ALEASSLPPPDPWLE | 771 | Q9Y2H0 | |
| PDRPWAKPEDPSLLE | 216 | P15121 | |
| CPEQFWEKYRPELPP | 251 | A6NCL7 | |
| EDPRFPKLQWPTPDL | 521 | Q6ZRP7 | |
| ESFWPDQNLPSLPPR | 291 | Q5JSJ4 | |
| FKDPDPWTPAALIPE | 401 | Q8IVL6 | |
| DTWKTDQRPTPEPFP | 456 | O60320 | |
| GSFEWAEDFPLLPPP | 1411 | Q96Q04 | |
| PLLVAEWSAPAAPPQ | 466 | Q86UP0 | |
| EPRPENSIFLKWPEP | 841 | P08069 | |
| PLNFLNWDPDRPSAP | 296 | O60449 | |
| PTAANAPDPLPEDWK | 1336 | Q8IWU2 | |
| WANKDPLPPLDPQAI | 2576 | Q92616 | |
| RPEKLKEPWPNSDPP | 186 | P16144 | |
| KEPWPNSDPPFSFKN | 191 | P16144 | |
| FPPPDLSWLKNEQPI | 2991 | Q96RW7 | |
| LAWPFPNLPPLEAMD | 286 | P48551 | |
| PDNEKSLDWFLPPAP | 26 | A2PYH4 | |
| WVPLPPSADDNLKTP | 886 | E5RHQ5 | |
| EFILDPPKPKPPAWF | 2326 | Q9ULT8 | |
| PEYLWDDRKPQPPSL | 316 | Q8N5D6 | |
| PAELKPFWERPPQDP | 96 | Q8NCL4 | |
| ELCPPDPAFAPLSSW | 11 | Q2WGN9 | |
| SPWKSPPQLRQFLPE | 466 | Q8IWF6 | |
| TFWPDSEPKPEQAPR | 71 | P10075 | |
| SKWDQPAPAPLLFLP | 16 | Q7Z7F0 | |
| PSWDLLEAPKDPFSI | 261 | Q9BZB8 | |
| PLKWPNPENFDPARF | 431 | Q16678 | |
| AEPPLEWPFPDLFSE | 321 | O43889 | |
| PEPPPEPAFSEAQKW | 16 | Q9UPQ0 | |
| LEAPPQDFPAPWAQA | 3961 | O75445 | |
| FLLPPDPSNPWLSDD | 296 | P49802 | |
| PLPKLFPRNWDDLDP | 2176 | A2VEC9 | |
| RWFDPLDPLEPEQDP | 1286 | O60292 | |
| PSEQEPKFPCKEWDP | 206 | Q6P3W7 | |
| PKFPCKEWDPNLPSL | 211 | Q6P3W7 | |
| LWPEPDFRNPPRKAS | 51 | Q9H5Q4 | |
| PDRPWAKPEDPSLLE | 216 | C9JRZ8 | |
| PLLGWKEPVPPDERF | 231 | P25100 | |
| GPWEPLALAPDFPAD | 256 | E9PGG2 | |
| PAGWLDDEPKFIPDP | 311 | O14967 | |
| LPVWSPKSFPNEVEP | 441 | Q9Y228 | |
| NPPPTFRKPELWSDD | 236 | Q13188 | |
| APLWPQSPDASDFLP | 331 | Q8N7U7 | |
| EDSWTLFKPPPVFPV | 331 | Q7Z417 | |
| WFRDGQLLPAPAPEP | 76 | Q15772 | |
| PLLDPSPQWPADLSF | 1816 | O15015 | |
| KFLPWSLAREPPPEA | 181 | Q9UQQ2 | |
| DPLLQEPPAWFKSFL | 56 | Q5BJF2 | |
| PTPPLQLKWDRDEGP | 261 | A8MUI8 | |
| PPPTEKDWPKDDEQD | 26 | Q6P2C0 | |
| SIDYPAKNDSPWAPP | 881 | O75362 | |
| APATLLEEWDPVPKP | 276 | Q9P2T0 | |
| QLLPPEPDDAFWGAP | 11 | Q66K66 | |
| PPPKLRQPELWSAEF | 246 | Q8NEV4 |